Target finder


Insert sequence accession number

Cancel

Record ID: NRN_CS106409

Description:Sequence 9 from Patent WO2005047458. Microorganisms for Therapy. Microorganisms for Therapy. Microorganisms for Therapy. Sequence 9 from Patent EP2028270. Sequence 9 from patent US 7588767. Sequence 9 from patent US 7588771. Sequence 9 from patent US 7662398. Sequence 9 from patent US 7754221. Sequence 9 from patent US 8021662. Sequence 9 from patent US 8221769. JP 2009201515-A/8: Microorganisms for Therapy.
Length:11096 bp
Found in databases: nrnl1
Found in the following 15 patents: WO2005047458 (lens, espacenet) JP2007524385 (lens, espacenet) JP3934673B1 (lens, espacenet) JP2007020586 (lens, espacenet) JP2008161196 (lens, espacenet) EP2028270 (lens, espacenet) US7588767 (lens, espacenet) US2005031643 (lens, espacenet) US7588771 (lens, espacenet) US2006051370 (lens, espacenet) US7662398 (lens, espacenet) US7754221 (lens, espacenet) US8021662 (lens, espacenet) US8221769 (lens, espacenet) JP2009201515 (lens, espacenet)

2 amplicons

View all records targeted by these methods

View these methods in JRC GMO-Matrix



0 1110 2219 3329 4438 5548 6658 7767 8877 9986 11096 QL-ELE-00-002 QL-ELE-00-003

Legend

Event-specific method
Element-specific method
Construct-specific method
Taxon-specific method

Record ID Database Record description Record length Taxon Method Amplicon size Match details
NRN_CS106409 nrnl1 Sequence 9 from Patent WO2005047458... 11096 bp unidentified QL-ELE-00-002 215 bp View
NRN_CS106409 nrnl1 Sequence 9 from Patent WO2005047458... 11096 bp unidentified QL-ELE-00-003 173 bp View


Related publications:

Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101. 

Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.